Buy & Sell InMode Ltd (INMD) – InMode Ltd Price Today
Aura AI Summary
InMode (INMD) trades at $14.41, down 0.69% on the day, with the stock showing recent volatility amid takeover speculation and a new share repurchase program. The company maintains strong profitability with a 25.33% net margin and has beaten earnings estimates for the last three consecutive quarters. Revenue guidance for FY2026 is reaffirmed between $365M-$375M, with Q1 2026 results expected on May 6, 2026.
The outlook is cautiously optimistic, supported by solid fundamentals and a low valuation (P/E of 10.08), but risks include potential market saturation in the U.S. and the recent termination of a strategic review process. Analyst sentiment is mixed, leaning slightly bullish with a 54.55% buy rating, though institutional interest appears steady.
Key Stats
- $913.00MMarket Cap
- TechnologySector
- -23.23%3M Drawdown
- $365.89MEnterprise Value
- -Dividend Yield
52W Low: $12.76
12 Mar 2026
52W High: $16.62
02 Feb 2026
InMode Ltd (INMD) is currently valued at a market capitalization of $913.00M, with an enterprise value of $365.89M. Over the past 52 weeks, InMode Ltd has traded between a low of $12.76 and a high of $16.62, highlighting its annual price range. Over the past three months, InMode Ltd has recorded a drawdown of -23.23%, reflecting recent price volatility.
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Technical Indicators
|
|
|
Overall Summary
Bearish (9)Neutral (7)Bullish (11)
News
People also bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions